← Back to Search

Mindfulness Meditation for Fibromyalgia

N/A

Recruiting

Led By Roland Staud, MD

Research Sponsored by University of Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 hr

Awards & highlights

Study Summary

This trial will evaluate how Breathing Attention Training (a form of mindfulness meditation) affects pain sensitivity in those with fibromyalgia. Results from testing brain areas & complex methods are too expensive, so quantitative sensory testing will be used.

Who is the study for?

This trial is for adults with fibromyalgia, a condition causing widespread pain, who've had symptoms for over 6 months and meet specific diagnostic criteria. Healthy individuals without chronic pain can also join as controls. Participants must stop taking certain medications like painkillers and antidepressants before the study.Check my eligibility

What is being tested?

The study tests Breathing and Attention Training (BAT), a type of mindfulness meditation that may reduce fibromyalgia symptoms and sensitivity to pain. It's compared against standard breathing control techniques using quantitative sensory testing to measure effects on pain modulation.See study design

What are the potential side effects?

Since BAT involves non-invasive mindfulness practices, significant side effects are not expected. However, participants might experience temporary discomfort or emotional distress during meditation sessions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 hr

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 hr

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 hr for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Ratings of Painful and Painless Sensory Stimuli

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Breathing and Attention Training (BAT)Experimental Treatment1 Intervention

Participants will be asked to do 20-minutes of focused breathing and attention training, involving focusing on taking deep breaths and becoming aware of the changing body sensations associated with breathing (mindfulness).

Group II: Controlled Deep BreathingActive Control1 Intervention

Participants will be asked to do 20-minutes of deep breathing and letting the body relax.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor

1,340 Previous Clinical Trials

715,665 Total Patients Enrolled

7 Trials studying Fibromyalgia

796 Patients Enrolled for Fibromyalgia

Roland Staud, MDPrincipal InvestigatorUniversity of Florida

4 Previous Clinical Trials

403 Total Patients Enrolled

4 Trials studying Fibromyalgia

403 Patients Enrolled for Fibromyalgia

Media Library

Breathing and Attention Training (BAT) Clinical Trial Eligibility Overview. Trial Name: NCT05773482 — N/A

Fibromyalgia Research Study Groups: Breathing and Attention Training (BAT), Controlled Deep Breathing

Fibromyalgia Clinical Trial 2023: Breathing and Attention Training (BAT) Highlights & Side Effects. Trial Name: NCT05773482 — N/A

Breathing and Attention Training (BAT) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05773482 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available openings within this clinical investigation?

"Per the clinicaltrials.gov entry, this specific trial is no longer enrolling patients as it was last revised on March 6th 2023. However, there are currently 90 other studies actively seeking participants."

Answered by AI

Is there an age cap for participants involved in this research?

"This trial is seeking out volunteers aged 18 or older but below 70 years of age."

Answered by AI

Are there any eligibility criteria that would prevent me from joining this investigation?

"To qualify for this medical study, candidates must have fibromyalgia and be younger than 70 years of age but older than 18. 40 participants are needed to complete the trial."

Answered by AI